Afuco™ Anti-HIV gp41 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-HIV gp41 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-HIV-1 gp41 antibodies are used for a therapeutic treatment against HIV infection by reducing viral load levels within an infected individual, thus prolonging the asymptomatic phase of HIV infection.
Supplier Creative Biolabs
Product # AFC-341CL
Pricing Inquiry
Host Human
Target HIV gp41
Species Reactivity HIV
Type ADCC enhanced antibody
Storage Store at -20°C. Open under aseptic conditions.
Feedback